BISvsIVV
ProShares UltraShort Nasdaq Biotechnology against iShares Core S&P 500 ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BIS | IVV | |
|---|---|---|
| Expense ratio | 0.95% | 0.030% |
| Assets | $1928.56T | $882.6B |
| Net flow, 1 month | — | −$4.7B |
| Net flow, 1 year | +$2K | +$69.9B |
| Return, YTD | -38.2% | +12.9% |
| Return, 1 year | -52.3% | +15.0% |
| Avg daily volume | 8K | 9.9M |
| Holdings | 7 | 507 |
| Listed | Apr 9, 2010 | May 15, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS